One participant (C124) initially investigated for CVID/other IEI, was diagnosed with Hyper-IgM-Syndrome (HIGM) following the identification of a pathogenic variant in the CD40 ligand gene (described elsewhere [37]). Here, CD40LG is linked to hyper-IgM syndrome type 1.